NCT07779889

Brief Summary

This pilot study will test whether a school-based neurodevelopmental brain-training program, called the Melillo Method®, is feasible to deliver and study in elementary and middle school students who are struggling with behavior and learning. The study will enroll about 34 children ages 8 and older at two schools in Illinois. Children will be identified by teachers and school staff as needing extra support, and families will complete a brief questionnaire to confirm eligibility. Children who qualify will be randomly assigned to start the program right away (24 weeks of sessions) or after a delay (12 weeks of sessions, starting partway through the study). This "delayed-start" design lets every enrolled child eventually receive the program while still allowing researchers to compare outcomes between children who started earlier versus later. The program combines sensory stimulation (lights, gentle vibration, scent), rhythm-based exercises, primitive reflex integration activities, and balance/coordination training, delivered by a trained clinician in small groups of two. Sessions occur three times per week for about 20 minutes each. Researchers will measure whether the study procedures are practical and acceptable. For example, how many eligible families enroll, how well families and teachers complete follow-up questionnaires, how well students tolerate the assessments, and how consistently families attend sessions. As a secondary goal, the study will explore whether children show changes in thinking skills, fine motor coordination, and emotional/behavioral functioning, measured using standardized tools (the NIH Toolbox and the Strengths and Difficulties Questionnaire) completed by the children, their parents, and their teachers. This is a feasibility study. It is not intended to prove that the program works, but rather to determine whether a larger, more rigorous trial is realistic and well-designed.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Sep 2026May 2027

First Submitted

Initial submission to the registry

August 13, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 21, 2026

Completed
24 days until next milestone

Study Start

First participant enrolled

September 14, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

September 22, 2026

Status Verified

September 1, 2026

Enrollment Period

8 months

First QC Date

August 13, 2026

Last Update Submit

September 21, 2026

Conditions

Keywords

Pilot ProjectsPediatricsMelillo Method

Outcome Measures

Primary Outcomes (7)

  • Proportion of consenting parents

    Number of parents who consent, divided by the total number of eligible students identified via the online screen. This assesses 'Consent rate'

    Through study completion (up to 10 months)

  • Proportion Strength and Difficulties Questionnaire - Teacher version (SDQ-T) completed

    The number of SDQ-T surveys completed, divided by the total number of SDQ-T surveys sent. This assesses teacher-level 'Response'

    Through study completion (up to 10 months)

  • Proportion Strength and Difficulties Questionnaire - Parent version (SDQ-P) completed

    The number of SDQ-T surveys completed, divided by the total number of SDQ-T surveys sent. This assesses parent-level 'Response'

    Through study completion (up to 10 months)

  • Proportion of completed assessment batteries

    The number of completed assessment batteries, divided by the total number of attempted assessment batteries. This assesses 'Tolerability'

    Through study completion (up to 10 months)

  • Proportion of students adhering to the care plan

    The number of enrolled students attending at least 90% of their scheduled therapy sessions, divided by the total number of students attending therapy (excludes sessions scheduled after withdrawal). This assesses 'Adherence'

    Through study completion (up to 10 months)

  • Proportion of students retained in the immediate-start arm

    The number of students allocated to the immediate-start arm attending the end-trial assessment session, divided by the total number of students allocated to the immediate-start arm. This assesses experimental arm 'Retention'

    Through study completion (up to 10 months)

  • Proportion of students retained in the delayed-start arm.

    Number of students in the delayed-start arm attending the end-trial assessment session divided by the total number of students allocated to the delayed-start arm. This assesses control-arm 'Retention'

    Through study completion (up to 10 months)

Secondary Outcomes (5)

  • Change difference in NIH Toolbox (v3) Cognition Battery Composites

    Through study completion (up to 10 months)

  • Change difference in NIH Toolbox (v3) Emotion Battery Composites

    Through study completion (up to 10 months)

  • Change difference in the NIH Toolbox (v3) 9-hold Pegboard Dexterity Test

    Through study completion (up to 10 months)

  • Change difference in the Strengths & Difficulties Questionnaire - Parent (SDQ-P)

    Through study completion (up to 10 months)

  • Change difference in the Strengths & Difficulties Questionnaire - Teacher (SDQ-T)

    Through study completion (up to 10 months)

Study Arms (2)

Immediate-start

EXPERIMENTAL

Participants in this arm will receive \~24 weeks (3x week) of Melillo Method therapy

Procedure: Melillo Method

Delayed-start

ACTIVE COMPARATOR

Participants in this arm will be allocated to a waitlist followed by \~12 weeks (3x week) of Melillo Method therapy

Procedure: Melillo Method

Interventions

The intervention is delivered by a Melillo Method-certified clinician and a trained assistant in dyadic (n=2) small-group format, three sessions weekly. This group size is intended to preserve a high clinician-to-student ratio for individualized manual therapy while allowing structured peer-to-peer engagement during cooperative timing tasks. Each intervention block begins and concludes with a standardized neurodevelopmental assessment (primitive reflex grading, postural and oculomotor evaluation, Interactive Metronome baseline timing metrics) to characterize functional status independent of the ongoing outcome battery. Participants are assigned to a right- or left-hemisphere-targeted stimulation protocol based on clinical synthesis of neurobehavioral history and observed asymmetry patterns, determining the laterality of sensory stimulation (visual, tactile-vibratory, olfactory, and auditory) and the directionality of oculomotor an

Also known as: Functional Neurology
Delayed-startImmediate-start

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • + years old
  • Attends Roodhouse Elementary or North Greene Jr. High School
  • Screening SDQ-P Total Difficulties Score ≥17 and Total Impact Score ≥2

You may not qualify if:

  • History of Epilepsy
  • Diagnosis of Oppositional Defiance Disorder (ODD) or Conduct Disorder (CD)
  • Impairments that preclude standardized administration of the assessments and/or therapy (e.g., uncorrected visual or hearing loss, paralysis of the arms or legs)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

North Greene School District

Roodhouse, Illinois, 62082, United States

RECRUITING

MeSH Terms

Conditions

Neurodevelopmental Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Tyson Perez

    Life University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Associate Vice President of Research

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Data analyst
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 13, 2026

First Posted

August 21, 2026

Study Start

September 14, 2026

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

September 22, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

Deidentified IPD necessary to reproduce results.

Shared Documents
ANALYTIC CODE
Time Frame
(start date): within 1 year of study completion. (end date): indefinitely
Access Criteria
IPD, metadata \& analytic code necessary to reproduce results will be made publicly accessible via a data repository
More information

Locations